Liwen Yu

Key Laboratory Of Cardiovascular Remodeling And Function Research, No. 107, Wenhua Xi Road
Jinan, 250012, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Macrophage USP7 aggravates acute myocardial infarction by inhibiting STING degradation through the ESCRT pathway.

Macrophage USP7 aggravates acute myocardial infarction by inhibiting STING degradation through the ESCRT pathway.

Journal: Cell death and differentiation

Published: May 05, 2026

Cardiomyocyte-Specific RNF128 Attenuates Pathological Cardiac Hypertrophy Progression by Stabilizing SERCA2a through Lys63-Linked Polyubiquitination.

Cardiomyocyte-Specific RNF128 Attenuates Pathological Cardiac Hypertrophy Progression by Stabilizing SERCA2a through Lys63-Linked Polyubiquitination.

Journal: Theranostics

Published: February 15, 2026

Macrophage PRMT9 Ameliorates Acute Myocardial Infarction by Promoting Symmetric Dimethylation and Degradation of STAT1.

Macrophage PRMT9 Ameliorates Acute Myocardial Infarction by Promoting Symmetric Dimethylation and Degradation of STAT1.

Journal: Circulation

Published: February 11, 2026

Macrophage-Specific E3 Ubiquitin Ligase TRIM31 Reduces Atherosclerotic Plaque Formation by Targeting LOX-1.

Macrophage-Specific E3 Ubiquitin Ligase TRIM31 Reduces Atherosclerotic Plaque Formation by Targeting LOX-1.

Journal: Circulation

Published: December 18, 2025

Macrophage SBK2 suppresses inflammation and atherosclerosis by NLRP3 phosphorylation.

Macrophage SBK2 suppresses inflammation and atherosclerosis by NLRP3 phosphorylation.

Journal: European heart journal

Published: March 17, 2025

E3 ubiquitin ligase RNF128 promotes Lys63-linked polyubiquitination on SRB1 in macrophages and aggravates atherosclerosis.

E3 ubiquitin ligase RNF128 promotes Lys63-linked polyubiquitination on SRB1 in macrophages and aggravates atherosclerosis.

Journal: Nature communications

Published: November 04, 2023

METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on Braf mRNA Promotes Macrophage Inflammatory Response and Atherosclerosis in Mice.

METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on Braf mRNA Promotes Macrophage Inflammatory Response and Atherosclerosis in Mice.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: March 23, 2023

E3 ligase RNF99 negatively regulates TLR-mediated inflammatory immune response via K48-linked ubiquitination of TAB2.

E3 ligase RNF99 negatively regulates TLR-mediated inflammatory immune response via K48-linked ubiquitination of TAB2.

Journal: Cell death and differentiation

Published: August 18, 2022

An intersegmental single-cell profile reveals aortic heterogeneity and identifies a novel Malat1+ vascular smooth muscle subtype involved in abdominal aortic aneurysm formation.

An intersegmental single-cell profile reveals aortic heterogeneity and identifies a novel Malat1+ vascular smooth muscle subtype involved in abdominal aortic aneurysm formation.

Journal: Signal transduction and targeted therapy

Published: August 27, 2021

Single-cell RNA sequencing analysis to characterize cells and gene expression landscapes in atrial septal defect.

Single-cell RNA sequencing analysis to characterize cells and gene expression landscapes in atrial septal defect.

Journal: Journal of cellular and molecular medicine

Published: May 12, 2021

The E3 ubiquitin ligase TRIM31 plays a critical role in hypertensive nephropathy by promoting proteasomal degradation of MAP3K7 in the TGF-β1 signaling pathway.

The E3 ubiquitin ligase TRIM31 plays a critical role in hypertensive nephropathy by promoting proteasomal degradation of MAP3K7 in the TGF-β1 signaling pathway.

Journal: Cell death and differentiation

Published: February 28, 2021

Impact of intracoronary nicorandil before stent deployment in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Impact of intracoronary nicorandil before stent deployment in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Journal: Experimental and therapeutic medicine

Published: December 01, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026